Skip to Main Content

Paper Details

Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nat Med
283
2019
APOE, APOE3, APOE3 Christchurch, Alzheimer's disease, PSEN1, R136S, autosomal dominant Alzheimer's disease, neurodegenerative, presenilin 1, tau
Author NameAffiliation
Reisa A SperlingMassachusetts General Hospital and Department of Neurology, Harvard Medical School
Reisa A SperlingBrigham and Women's Hospital and the Department of Neurology, Harvard Medical School
Kewei ChenThe Banner Alzheimer's Institute
Kewei ChenUniversity of Arizona
Kewei ChenArizona State University
Matthew J HuentelmanThe Translational Genomics Research Institute
Xiaowu GaiCenter for Personalized Medicine, Children's Hospital Los Angeles
Xiaowu GaiKeck School of Medicine of University of Southern California
Moiz BootwallaCenter for Personalized Medicine, Children's Hospital Los Angeles
Jianling JiCenter for Personalized Medicine, Children's Hospital Los Angeles
Jianling JiKeck School of Medicine of University of Southern California
John B MillerHarvard Medical School
Pierre N TariotThe Banner Alzheimer's Institute
Pierre N TariotUniversity of Arizona
Keith A JohnsonMassachusetts General Hospital and Department of Neurology, Harvard Medical School
Keith A JohnsonBrigham and Women's Hospital and the Department of Neurology, Harvard Medical School
Keith A JohnsonMassachusetts General Hospital and Department of Radiology, Harvard Medical School
Eric M ReimanThe Banner Alzheimer's Institute
Eric M ReimanUniversity of Arizona
Eric M ReimanArizona State University
Eric M ReimanThe Translational Genomics Research Institute
  • 1 - 21

Datasets